BAALC, BAALC binder of MAP3K1 and KLF4, 79870

N. diseases: 47; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual
0.030 AlteredExpression phenotype BEFREE Thus, BAALC expression-based MRD detection during therapy may be considered a strategy to identify patients at high risk of relapse. 27662611 2016
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual
0.030 Biomarker phenotype BEFREE This study showed that higher post-HSCT BAALC and WT1 expressions in patients with CBF-AML may be good markers of minimal residual disease for the prediction of survival and relapse after HSCT. 23672350 2013
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual
0.030 AlteredExpression phenotype BEFREE To our knowledge, this is the first report concerning the use of BAALC mRNA expression for MRD monitoring. 20376583 2010